Esmolol (Brevibloc)
Indications
- Hypertension (see Hypertension, [[Hypertension]])
- Rate Control of Supraventricular Arrhythmias
Pharmacology
Metabolism
Half-Life
Administration
- IV: load 1000 mcg/kg IVP over 30 sec, then drip 150-300 mcg/kg/min
- Taper dose gradually to discontinue
Dose Adjustment
- Hepatic: undefined
- Renal
- Elevated metabolite levels in end-stage renal disease
- Not dialyzable
Adverse Effects
Cardiovascular Adverse Effects
Pulmonary Adverse Effects
Other Adverse Effects
References